Login / Signup

Humoral response after accelerated schedule of HBV vaccination in MS patients before anti-CD20 therapy.

Elisabeth MaillartEve TodescoLambert AssoumouYsoline BeigneuxCatherine LubetzkiCaroline PapeixRaphael De PazAnne-Laure DubessySiham DjebaraCéline LouapreValérie Pourcher
Published in: Journal of neurology (2024)
Keyphrases
  • end stage renal disease
  • newly diagnosed
  • immune response
  • chronic kidney disease
  • hepatitis b virus
  • mass spectrometry
  • prognostic factors
  • ms ms
  • mesenchymal stem cells
  • cell therapy
  • smoking cessation
  • nk cells